STADA ARZNEIMITTEL AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
A23L FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT 163
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0304,259 COMPOSITIONJun 30, 17Oct 26, 17[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9724326 Method of treating celiac diseaseDec 19, 12Aug 08, 17[A61K]
9364437 Diaminooxidase-containing pharmaceutical compositionsApr 04, 14Jun 14, 16[A61K, A23L]
9144602 Treatment of fructose malabsorptionAug 19, 09Sep 29, 15[A61K]
8716244 Diaminooxidase-containing pharmaceutical compositionsAug 24, 10May 06, 14[A61K, C12N]
8003343 Method for determining diamine oxidaseNov 17, 06Aug 23, 11[C12Q]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2006/0089,328 Ready-to-use gemcitabine solutionsAbandonedOct 22, 04Apr 27, 06[A61K]
2006/0089,329 Ready-to-use gemcitabine solution concentratesAbandonedOct 22, 04Apr 27, 06[A61K]
2006/0063,720 Oxaliplatin solution concentrateAbandonedSep 22, 04Mar 23, 06[A61K]
2006/0063,833 Ready-to-use oxaliplatin solutionsAbandonedSep 22, 04Mar 23, 06[A61K]
5143940 Ambiphile creamExpiredDec 20, 90Sep 01, 92[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.